Abstract
The present study aimed to address the pharmacogenetic role of BAG1 in platinum-based chemotherapy in advanced non-small-cell lung cancer (NSCLC) and in cultured human lung adenocarcinoma A549 cells. A total of 108 NSCLC patients (stages I-IIIA) were treated with a standard chemotherapy regimen of cisplatin plus vinorelbine. Additionally, in vitro cultured A549 cells were treated with cisplatin in the presence or absence of tunicamycin. Cell proliferation was determined by MTT assay and protein levels were assessed via western blot analysis. Patients with BAG1-positive expression were revealed to have a prolonged survival time (progression-free survival, 24.0 months) compared with that of patients without BAG1 expression (21.6 months; χ(2)=18.018, P<0.05). Treatment of A549 cells with tunicamycin followed by cisplatin resulted in elevated BAG1 levels. In addition, tunicamycin was found to significantly enhance cisplatin-induced growth inhibition and apoptosis in A549 cells. The results indicate that BAG1 is important in cisplatin-induced cell death in lung adenocarcinoma, suggesting that endoplasmic reticulum stress may promote the sensitivity of NSCLC patients to chemotherapy.
References
Jan 27, 1995·Cell·S TakayamaJ C Reed
Jan 19, 2000·Nature·T NakagawaJ Yuan
Feb 3, 2000·Journal of the National Cancer Institute·P TherasseS G Gwyther
Aug 9, 2001·International Journal of Cancer. Journal International Du Cancer·S RorkeS C Tang
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Jul 5, 2002·The Journal of Biological Chemistry·Nobuhiro MorishimaYukuto Yasuhiko
Aug 22, 2002·British Journal of Cancer·J S Waters, M E R O'Brien
Jan 27, 2004·Nature Reviews. Cancer·Cornelia M UlrichHoward L McLeod
Jun 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sarada GurubhagavatulaDavid C Christiani
Jul 29, 2004·DNA Repair·Marie Fernet, Janet Hall
Oct 12, 2004·The International Journal of Biochemistry & Cell Biology·Paul A TownsendDavid S Latchman
Nov 25, 2004·BMC Cancer·Rudolf GötzUlf R Rapp
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
Apr 7, 2006·The Journal of Biological Chemistry·Yinfei TanPeter A Greer
May 2, 2006·Cancer·Richard BootonNicholas Thatcher
Apr 4, 2007·Annals of the New York Academy of Sciences·Su-Hyeong KimYong-Sang Song
Jun 5, 2007·Journal of Cellular Biochemistry·Ling YangWalter E Horton
Sep 15, 2007·Human Molecular Genetics·Athena MatakidouRichard S Houlston
Oct 16, 2008·Pharmacogenetics and Genomics·Xifeng WuMargaret R Spitz
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Sep 23, 2014·International Journal of Cancer. Journal International Du Cancer·Hongmei ZengXue Qin Yu
Citations
Sep 30, 2017·Cell Cycle·Jing SunYue Wang
Nov 29, 2017·Oncotarget·Yihan MaHan-Xiang An
Oct 19, 2017·Molecular Medicine Reports·Shan ShiHaibo Li
Mar 30, 2017·Oncology Reports·Ruirui ChengGuoqiang Zhao
Oct 19, 2019·Aging·Bangbei WanCai Lv
Sep 8, 2017·Journal of Translational Medicine·Shutong LiuYulin Li
Sep 26, 2020·Canadian Journal of Physiology and Pharmacology·Katarina MihajlovicSlobodan Novokmet